CMT1E
MCID: CHR629
MIFTS: 47

Charcot-Marie-Tooth Disease and Deafness (CMT1E)

Categories: Ear diseases, Fetal diseases, Genetic diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Charcot-Marie-Tooth Disease and Deafness

MalaCards integrated aliases for Charcot-Marie-Tooth Disease and Deafness:

Name: Charcot-Marie-Tooth Disease and Deafness 57 12 53 29 6
Charcot-Marie-Tooth Disease Type 1e 12 53 59 15
Cmt1e 57 12 59 75
Charcot-Marie-Tooth Disease, Demyelinating, Type 1e 57 53 73
Charcot-Marie-Tooth Disease, Type I 29 6 40
Charcot-Marie-Tooth Disease Type 1 12 53 15
Charcot-Marie-Tooth Neuropathy and Deafness, Autosomal Dominant 57 53
Charcot-Marie-Tooth Disease Demyelinating Type 1e 12 75
Hereditary Motor and Sensory Neuropathy Type 1 12 53
Charcot-Marie-Tooth Disease, Type 1e 57 13
Autosomal Dominant Charcot-Marie-Tooth Neuropathy and Deafness 12
Autosomal Dominant Demyelinating Charcot-Marie-Tooth Disease 53
Charcot-Marie-Tooth Disease and Deafness Autosomal Dominant 75
Charcot-Marie-Tooth Disease, Demyelinating, Type 1e; Cmt1e 57
Hereditary Motor and Sensory Neuropathy Type I 73
Charcot-Marie-Tooth Disease-Deafness Syndrome 59
Hereditary Motor and Sensory Neuropathy 1 53
Charcot-Marie-Tooth Neuropathy Type 1e 75
Charcot-Marie-Tooth Neuropathy Type 1 53
Charcot-Marie-Tooth Disease-Deafness 12
Charcot-Marie-Tooth Disease, Type Ie 40
Charcot Marie Tooth Disease Type 1e 53
Charcot-Marie-Tooth Disease 1e 75
Charcot-Marie-Tooth Type 1 53
Cmt 1e 53
Hmsn1 53
Cmt1 53

Characteristics:

Orphanet epidemiological data:

59
charcot-marie-tooth disease type 1e
Inheritance: Autosomal dominant; Age of onset: Childhood,Infancy; Age of death: normal life expectancy;

OMIM:

57
Inheritance:
autosomal dominant

Miscellaneous:
usually begins in feet and legs (peroneal distribution)
upper limb involvement usually occurs later
childhood onset
allelic disorders with overlapping phenotypes include cmt1a , hereditary neuropathy with liability to pressure palsies (hnpp, ), and dejerine-sottas syndrome (dss, )


HPO:

32
charcot-marie-tooth disease and deafness:
Onset and clinical course childhood onset juvenile onset
Inheritance autosomal dominant inheritance


Classifications:



External Ids:

OMIM 57 118300
Disease Ontology 12 DOID:0050538 DOID:0110153
ICD10 33 G60.0
Orphanet 59 ORPHA90658
MESH via Orphanet 45 C537986 C538078
ICD10 via Orphanet 34 G60.0
UMLS via Orphanet 74 C3495591 C1861669 C2931686
MeSH 44 D002607

Summaries for Charcot-Marie-Tooth Disease and Deafness

NIH Rare Diseases : 53 Charcot-Marie-Tooth disease type 1 (CMT1) is a type of peripheral neuropathy, a condition affecting the transmission of information between the central nervous system (brain and spinal cord) and the rest of the body. Symptoms often begin between age 5 and 25, and the condition is usually slowly progressive. Signs and symptoms include distal muscle weakness and wasting (atrophy); sensory loss; and slow nerve conduction velocity. It is often associated with pes cavus foot deformity (high arch) and bilateral foot drop. Fewer than 5% of people with CMT1 become wheelchair dependent. CMT1 is inherited in an autosomal dominant manner. There are 6 different subtypes CMT1A CMT1B, CMT1C, CMT1D and CMT1F/ CMT2E, caused by different pathogenic variants (mutations)involving the PMP22 gene (designated CMT1A), or the MPZ, LITAF, EGR2, PMP22 or NEFL genes. Treatment may involve physical or occupational therapy; the use of special shoes, braces or other orthopedic devices; surgery for severe pes cavus; canes or wheelchairs for mobility; and pain medication as needed.

MalaCards based summary : Charcot-Marie-Tooth Disease and Deafness, also known as charcot-marie-tooth disease type 1e, is related to charcot-marie-tooth disease, x-linked dominant, 1 and roussy-levy hereditary areflexic dystasia. An important gene associated with Charcot-Marie-Tooth Disease and Deafness is PMP22 (Peripheral Myelin Protein 22), and among its related pathways/superpathways is Neural Crest Differentiation. Affiliated tissues include brain and spinal cord, and related phenotypes are sensorineural hearing impairment and pes cavus

Disease Ontology : 12 A Charcot-Marie-Tooth disease type 1 that has material basis in autosomal dominant mutation in the peripheral myelin protein-22 gene (PMP22).

UniProtKB/Swiss-Prot : 75 Charcot-Marie-Tooth disease 1E: An autosomal dominant form of Charcot-Marie-Tooth disease characterized by the association of sensorineural hearing loss with peripheral demyelinating neuropathy.

Description from OMIM: 118300

Related Diseases for Charcot-Marie-Tooth Disease and Deafness

Diseases related to Charcot-Marie-Tooth Disease and Deafness via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 86)
# Related Disease Score Top Affiliating Genes
1 charcot-marie-tooth disease, x-linked dominant, 1 33.4 GJB1 MPZ PMP22
2 roussy-levy hereditary areflexic dystasia 32.6 MPZ PMP22
3 charcot-marie-tooth disease, demyelinating, type 1f 32.5 GJB1 MPZ PMP22
4 charcot-marie-tooth disease, demyelinating, type 1c 32.4 EGR2 GJB1 KIF1B LITAF MPZ PMP22
5 charcot-marie-tooth disease, demyelinating, type 1d 32.2 EGR2 GJB1 KIF1B MPZ MTMR2 PMP22
6 charcot-marie-tooth disease, demyelinating, type 1a 31.7 COX10 EGR2 GDAP1 GJB1 KIF1B MFN2
7 charcot-marie-tooth disease, axonal, type 2i 31.6 KIF1B MPZ
8 charcot-marie-tooth disease, axonal, type 2q 31.6 EGR2 MPZ
9 charcot-marie-tooth disease, axonal, type 2j 31.6 KIF1B MPZ
10 charcot-marie-tooth disease, axonal, type 2a1 31.6 KIF1B MFN2
11 charcot-marie-tooth disease, axonal, type 2f 31.5 GJB1 KIF1B MPZ
12 charcot-marie-tooth disease, type 4b3 31.5 GDAP1 MTMR2
13 charcot-marie-tooth disease, demyelinating, type 4f 31.5 GDAP1 MTMR2
14 charcot-marie-tooth disease, type 4b2 31.5 GDAP1 MTMR2
15 charcot-marie-tooth disease, type 4a 31.4 GDAP1 MTMR2
16 charcot-marie-tooth disease, axonal, type 2d 31.4 GJB1 KIF1B MPZ PMP22
17 charcot-marie-tooth disease, demyelinating, type 1b 31.4 EGR2 GJB1 KIF1B MPZ MTMR2 PMP22
18 charcot-marie-tooth disease, axonal, type 2k 31.4 GDAP1 KIF1B MFN2
19 charcot-marie-tooth disease, type 4b1 31.4 GDAP1 MTMR2
20 charcot-marie-tooth disease, axonal, type 2l 31.4 KIF1B MPZ
21 hereditary motor and sensory neuropathy, type iic 31.2 GDAP1 GJB1 KIF1B MFN2 MPZ
22 charcot-marie-tooth disease, axonal, type 2b 31.2 EGR2 GJB1 KIF1B MPZ PMP22 SULT2B1
23 charcot-marie-tooth disease, axonal, type 2e 31.1 EGR2 GDAP1 GJB1 KIF1B MFN2 MPZ
24 charcot-marie-tooth disease, type 4d 31.1 GDAP1 GJB1 MFN2 NTF3 SH3TC2
25 cauda equina syndrome 30.8 EGR2 PMP22
26 polyneuropathy 30.7 GDAP1 MPZ PMP22
27 neuropathy 30.4 EGR2 GDAP1 GJB1 MFN2 MPZ PMP22
28 tooth disease 30.0 EGR2 GDAP1 GJB1 KIF1B LITAF MFN2
29 sensory peripheral neuropathy 29.5 EGR2 GDAP1 GJB1 LITAF MFN2 MPZ
30 neuropathy, hereditary, with liability to pressure palsies 29.5 ADCY10 COX10 EGR2 GDAP1 GJB1 KIF1B
31 charcot-marie-tooth disease 29.3 ARHGEF10 CDRT1 COX10 EGR2 GDAP1 GJB1
32 neuropathy, congenital hypomyelinating or amyelinating, autosomal recessive 29.2 EGR2 GDAP1 GJB1 KIF1B LITAF MFN2
33 pmp2-related charcot-marie-tooth disease type 1 12.5
34 neuropathy, hereditary motor and sensory, with deafness, mental retardation, and absent sensory large myelinated fibers 11.9
35 charcot-marie-tooth disease, dominant intermediate a 11.1
36 charcot-marie-tooth disease, type 4c 10.8
37 charcot-marie-tooth disease, axonal, type 2b1 10.8
38 charcot-marie-tooth disease, axonal, type 2b2 10.8
39 charcot-marie-tooth disease, dominant intermediate b 10.8
40 charcot-marie-tooth disease, axonal, autosomal dominant, type 2a2a 10.8
41 charcot-marie-tooth disease, type 4h 10.8
42 charcot-marie-tooth disease, type 4j 10.8
43 charcot-marie-tooth disease, axonal, type 2n 10.8
44 charcot-marie-tooth disease, axonal, type 2o 10.8
45 charcot-marie-tooth disease, axonal, type 2p 10.8
46 charcot-marie-tooth disease, axonal, type 2r 10.8
47 charcot-marie-tooth disease, axonal, type 2u 10.8
48 charcot-marie-tooth disease, axonal, type 2v 10.8
49 charcot-marie-tooth disease, axonal, type 2w 10.8
50 charcot-marie-tooth disease, axonal, type 2x 10.8

Graphical network of the top 20 diseases related to Charcot-Marie-Tooth Disease and Deafness:



Diseases related to Charcot-Marie-Tooth Disease and Deafness

Symptoms & Phenotypes for Charcot-Marie-Tooth Disease and Deafness

Symptoms via clinical synopsis from OMIM:

57
Skeletal Feet:
pes cavus
foot deformities
pes calcaneovarus
hammertoes

Head And Neck Ears:
sensorineural hearing loss

Neurologic Peripheral Nervous System:
areflexia
hyporeflexia
distal sensory impairment
distal limb muscle weakness due to peripheral neuropathy
distal limb muscle atrophy due to peripheral neuropathy
more
Skeletal Hands:
claw hand deformities


Clinical features from OMIM:

118300

Human phenotypes related to Charcot-Marie-Tooth Disease and Deafness:

32 (show all 14)
# Description HPO Frequency HPO Source Accession
1 sensorineural hearing impairment 32 HP:0000407
2 pes cavus 32 HP:0001761
3 decreased motor nerve conduction velocity 32 HP:0003431
4 areflexia 32 HP:0001284
5 split hand 32 HP:0001171
6 hyporeflexia 32 HP:0001265
7 foot dorsiflexor weakness 32 HP:0009027
8 limb muscle weakness 32 HP:0003690
9 hammertoe 32 HP:0001765
10 distal muscle weakness 32 HP:0002460
11 steppage gait 32 HP:0003376
12 distal amyotrophy 32 HP:0003693
13 distal sensory impairment 32 HP:0002936
14 talipes calcaneovalgus 32 HP:0001884

MGI Mouse Phenotypes related to Charcot-Marie-Tooth Disease and Deafness:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10 COX10 EGR2 GDAP1 GJB1 KIF1B MFN2
2 cellular MP:0005384 9.85 ADCY10 COX10 EGR2 GDAP1 GJB1 LITAF
3 homeostasis/metabolism MP:0005376 9.77 ADCY10 COX10 EGR2 GDAP1 GJB1 KIF1B
4 nervous system MP:0003631 9.4 COX10 EGR2 GDAP1 GJB1 KIF1B LITAF

Drugs & Therapeutics for Charcot-Marie-Tooth Disease and Deafness

Search Clinical Trials , NIH Clinical Center for Charcot-Marie-Tooth Disease and Deafness

Genetic Tests for Charcot-Marie-Tooth Disease and Deafness

Genetic tests related to Charcot-Marie-Tooth Disease and Deafness:

# Genetic test Affiliating Genes
1 Charcot-Marie-Tooth Disease and Deafness 29 PMP22
2 Charcot-Marie-Tooth Disease, Type I 29

Anatomical Context for Charcot-Marie-Tooth Disease and Deafness

MalaCards organs/tissues related to Charcot-Marie-Tooth Disease and Deafness:

41
Brain, Spinal Cord

Publications for Charcot-Marie-Tooth Disease and Deafness

Articles related to Charcot-Marie-Tooth Disease and Deafness:

# Title Authors Year
1
A unique point mutation in the PMP22 gene is associated with Charcot- Marie-Tooth disease and deafness. ( 10330345 )
1999
2
Hereditary hypertrophic neuropathy combining features of tic douloureux, Charcot-Marie-Tooth disease, and deafness. ( 196788 )
1977

Variations for Charcot-Marie-Tooth Disease and Deafness

UniProtKB/Swiss-Prot genetic disease variations for Charcot-Marie-Tooth Disease and Deafness:

75
# Symbol AA change Variation ID SNP ID
1 PMP22 p.Ala67Pro VAR_009661 rs104894623
2 PMP22 p.Thr23Arg VAR_029961
3 PMP22 p.Trp28Arg VAR_029963 rs104894626

ClinVar genetic disease variations for Charcot-Marie-Tooth Disease and Deafness:

6 (show top 50) (show all 677)
# Gene Variation Type Significance SNP ID Assembly Location
1 PMP22 NM_000304.3(PMP22): c.47T> C (p.Leu16Pro) single nucleotide variant Pathogenic rs104894617 GRCh37 Chromosome 17, 15163998: 15163998
2 PMP22 NM_000304.3(PMP22): c.47T> C (p.Leu16Pro) single nucleotide variant Pathogenic rs104894617 GRCh38 Chromosome 17, 15260681: 15260681
3 PMP22 NM_000304.3(PMP22): c.353C> T (p.Thr118Met) single nucleotide variant Conflicting interpretations of pathogenicity rs104894619 GRCh37 Chromosome 17, 15134364: 15134364
4 PMP22 NM_000304.3(PMP22): c.353C> T (p.Thr118Met) single nucleotide variant Conflicting interpretations of pathogenicity rs104894619 GRCh38 Chromosome 17, 15231047: 15231047
5 PMP22 NM_000304.3(PMP22): c.215C> T (p.Ser72Leu) single nucleotide variant Pathogenic rs104894621 GRCh37 Chromosome 17, 15142892: 15142892
6 PMP22 NM_000304.3(PMP22): c.215C> T (p.Ser72Leu) single nucleotide variant Pathogenic rs104894621 GRCh38 Chromosome 17, 15239575: 15239575
7 PMP22 NM_000304.3(PMP22): c.36C> A (p.His12Gln) single nucleotide variant Pathogenic rs104894622 GRCh37 Chromosome 17, 15164009: 15164009
8 PMP22 NM_000304.3(PMP22): c.36C> A (p.His12Gln) single nucleotide variant Pathogenic rs104894622 GRCh38 Chromosome 17, 15260692: 15260692
9 PMP22 NM_000304.3(PMP22): c.199G> C (p.Ala67Pro) single nucleotide variant Pathogenic rs104894623 GRCh37 Chromosome 17, 15142908: 15142908
10 PMP22 NM_000304.3(PMP22): c.199G> C (p.Ala67Pro) single nucleotide variant Pathogenic rs104894623 GRCh38 Chromosome 17, 15239591: 15239591
11 PMP22 NM_000304.3(PMP22): c.82T> C (p.Trp28Arg) single nucleotide variant Pathogenic rs104894626 GRCh37 Chromosome 17, 15162507: 15162507
12 PMP22 NM_000304.3(PMP22): c.82T> C (p.Trp28Arg) single nucleotide variant Pathogenic rs104894626 GRCh38 Chromosome 17, 15259190: 15259190
13 PMP22 NM_000304.3(PMP22): c.344_355delCCATCTACACGG (p.Ala115_Thr118del) deletion Pathogenic rs786205111 GRCh38 Chromosome 17, 15231045: 15231056
14 PMP22 NM_000304.3(PMP22): c.344_355delCCATCTACACGG (p.Ala115_Thr118del) deletion Pathogenic rs786205111 GRCh37 Chromosome 17, 15134362: 15134373
15 PMP22 NM_000304.3(PMP22): c.469C> T (p.Arg157Trp) single nucleotide variant Pathogenic rs28936682 GRCh37 Chromosome 17, 15134248: 15134248
16 PMP22 NM_000304.3(PMP22): c.469C> T (p.Arg157Trp) single nucleotide variant Pathogenic rs28936682 GRCh38 Chromosome 17, 15230931: 15230931
17 MPZ NM_000530.7(MPZ): c.270C> A (p.Asp90Glu) single nucleotide variant Pathogenic rs121913584 GRCh37 Chromosome 1, 161276676: 161276676
18 MPZ NM_000530.7(MPZ): c.270C> A (p.Asp90Glu) single nucleotide variant Pathogenic rs121913584 GRCh38 Chromosome 1, 161306886: 161306886
19 MPZ NM_000530.7(MPZ): c.409G> A (p.Gly137Ser) single nucleotide variant Likely pathogenic rs121913588 GRCh37 Chromosome 1, 161276537: 161276537
20 MPZ NM_000530.7(MPZ): c.409G> A (p.Gly137Ser) single nucleotide variant Likely pathogenic rs121913588 GRCh38 Chromosome 1, 161306747: 161306747
21 MPZ NM_000530.7(MPZ): c.293G> C (p.Arg98Pro) single nucleotide variant Pathogenic rs121913589 GRCh37 Chromosome 1, 161276653: 161276653
22 MPZ NM_000530.7(MPZ): c.293G> C (p.Arg98Pro) single nucleotide variant Pathogenic rs121913589 GRCh38 Chromosome 1, 161306863: 161306863
23 MPZ NM_000530.7(MPZ): c.292C> T (p.Arg98Cys) single nucleotide variant Pathogenic rs121913590 GRCh37 Chromosome 1, 161276654: 161276654
24 MPZ NM_000530.7(MPZ): c.292C> T (p.Arg98Cys) single nucleotide variant Pathogenic rs121913590 GRCh38 Chromosome 1, 161306864: 161306864
25 MPZ NM_000530.7(MPZ): c.293G> A (p.Arg98His) single nucleotide variant Pathogenic/Likely pathogenic rs121913589 GRCh37 Chromosome 1, 161276653: 161276653
26 MPZ NM_000530.7(MPZ): c.293G> A (p.Arg98His) single nucleotide variant Pathogenic/Likely pathogenic rs121913589 GRCh38 Chromosome 1, 161306863: 161306863
27 MPZ NM_000530.7(MPZ): c.341T> C (p.Ile114Thr) single nucleotide variant Uncertain significance rs267607241 GRCh37 Chromosome 1, 161276605: 161276605
28 MPZ NM_000530.7(MPZ): c.341T> C (p.Ile114Thr) single nucleotide variant Uncertain significance rs267607241 GRCh38 Chromosome 1, 161306815: 161306815
29 MPZ NM_000530.7(MPZ): c.371C> T (p.Thr124Met) single nucleotide variant Pathogenic rs121913595 GRCh37 Chromosome 1, 161276575: 161276575
30 MPZ NM_000530.7(MPZ): c.371C> T (p.Thr124Met) single nucleotide variant Pathogenic rs121913595 GRCh38 Chromosome 1, 161306785: 161306785
31 MPZ NM_000530.7(MPZ): c.103G> T (p.Asp35Tyr) single nucleotide variant Uncertain significance rs121913596 GRCh37 Chromosome 1, 161277179: 161277179
32 MPZ NM_000530.7(MPZ): c.103G> T (p.Asp35Tyr) single nucleotide variant Uncertain significance rs121913596 GRCh38 Chromosome 1, 161307389: 161307389
33 MPZ NM_000530.7(MPZ): c.131C> T (p.Ser44Phe) single nucleotide variant Pathogenic rs121913598 GRCh37 Chromosome 1, 161277151: 161277151
34 MPZ NM_000530.7(MPZ): c.131C> T (p.Ser44Phe) single nucleotide variant Pathogenic rs121913598 GRCh38 Chromosome 1, 161307361: 161307361
35 MPZ NM_000530.7(MPZ): c.308G> A (p.Gly103Glu) single nucleotide variant Likely pathogenic rs121913600 GRCh37 Chromosome 1, 161276638: 161276638
36 MPZ NM_000530.7(MPZ): c.308G> A (p.Gly103Glu) single nucleotide variant Likely pathogenic rs121913600 GRCh38 Chromosome 1, 161306848: 161306848
37 MPZ NM_000530.7(MPZ): c.233C> T (p.Ser78Leu) single nucleotide variant Pathogenic rs121913601 GRCh37 Chromosome 1, 161277049: 161277049
38 MPZ NM_000530.7(MPZ): c.233C> T (p.Ser78Leu) single nucleotide variant Pathogenic rs121913601 GRCh38 Chromosome 1, 161307259: 161307259
39 MPZ NM_000530.7(MPZ): c.434A> C (p.Tyr145Ser) single nucleotide variant Pathogenic rs121913603 GRCh37 Chromosome 1, 161276512: 161276512
40 MPZ NM_000530.7(MPZ): c.434A> C (p.Tyr145Ser) single nucleotide variant Pathogenic rs121913603 GRCh38 Chromosome 1, 161306722: 161306722
41 EGR2 NM_000399.4(EGR2): c.1075C> T (p.Arg359Trp) single nucleotide variant Pathogenic rs104894161 GRCh37 Chromosome 10, 64573323: 64573323
42 EGR2 NM_000399.4(EGR2): c.1075C> T (p.Arg359Trp) single nucleotide variant Pathogenic rs104894161 GRCh38 Chromosome 10, 62813563: 62813563
43 EGR2 NM_000399.4(EGR2): c.1142G> A (p.Arg381His) single nucleotide variant Pathogenic rs281865137 GRCh37 Chromosome 10, 64573256: 64573256
44 EGR2 NM_000399.4(EGR2): c.1142G> A (p.Arg381His) single nucleotide variant Pathogenic rs281865137 GRCh38 Chromosome 10, 62813496: 62813496
45 MPZ NM_000530.7(MPZ): c.244T> C (p.Tyr82His) single nucleotide variant Pathogenic rs281865124 GRCh37 Chromosome 1, 161276702: 161276702
46 MPZ NM_000530.7(MPZ): c.244T> C (p.Tyr82His) single nucleotide variant Pathogenic rs281865124 GRCh38 Chromosome 1, 161306912: 161306912
47 MPZ NM_000530.7(MPZ): c.487G> C (p.Gly163Arg) single nucleotide variant Pathogenic/Likely pathogenic rs281865128 GRCh37 Chromosome 1, 161276216: 161276216
48 MPZ NM_000530.7(MPZ): c.487G> C (p.Gly163Arg) single nucleotide variant Pathogenic/Likely pathogenic rs281865128 GRCh38 Chromosome 1, 161306426: 161306426
49 MPZ NM_000530.7(MPZ): c.670G> T (p.Asp224Tyr) single nucleotide variant Pathogenic rs267607247 GRCh37 Chromosome 1, 161275743: 161275743
50 MPZ NM_000530.7(MPZ): c.670G> T (p.Asp224Tyr) single nucleotide variant Pathogenic rs267607247 GRCh38 Chromosome 1, 161305953: 161305953

Expression for Charcot-Marie-Tooth Disease and Deafness

Search GEO for disease gene expression data for Charcot-Marie-Tooth Disease and Deafness.

Pathways for Charcot-Marie-Tooth Disease and Deafness

Pathways related to Charcot-Marie-Tooth Disease and Deafness according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.81 GJB1 MPZ PMP22

GO Terms for Charcot-Marie-Tooth Disease and Deafness

Cellular components related to Charcot-Marie-Tooth Disease and Deafness according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 axon GO:0030424 8.92 ADCY10 KIF1B MTMR2 NTF3

Biological processes related to Charcot-Marie-Tooth Disease and Deafness according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein targeting to mitochondrion GO:0006626 9.4 GDAP1 MFN2
2 mitochondrial fission GO:0000266 9.37 COX10 GDAP1
3 myelination in peripheral nervous system GO:0022011 9.32 ARHGEF10 SH3TC2
4 mitochondrial fusion GO:0008053 9.26 GDAP1 MFN2
5 myelin assembly GO:0032288 9.16 MTMR2 PMP22
6 myelination GO:0042552 9.13 EGR2 MPZ PMP22
7 peripheral nervous system development GO:0007422 8.8 EGR2 NTF3 PMP22

Sources for Charcot-Marie-Tooth Disease and Deafness

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....